Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback